Table.
Patients’ Characteristics.
| Total | Group A: Duodenal involvement positive |
Group B: Duodenal involvement negative |
Group C: No biopsy of the duodenum |
|
|---|---|---|---|---|
| Number (N) | 24 | 17 | 2 | 5 |
| Age (median, years) | 66 | 57 | 76 | 70 |
| Sex, male | 19 (79.2%) | 14 (82.4%) | 1 (50.0%) | 4 (80.0%) |
| Involved sites | ||||
| Stomach | 22 (91.7%) | 15 (88.2%) | 2 (100%) | 5 (100%) |
| Duodenum | 17 (70.1%) | 17 (100%) | 0 | NA |
| Positive GI symptoms during EGD | 8 (33.3%) | 6 (35.3%) | 1 (50.0%) | 1 (20.0%) |
| White villi observed during EGD | 18 (75.0%) | 15 (88.2%) | 2 (100%) | 1 (20.0%) |
| Period of consuming lanthanum carbonate (median, months) | 56 | 56 | NA* | 81 |
GI: gastrointestinal, EGD: esophagogastroduodenoscopy, NA: not available
*The duration of consumption of lanthanum carbonate was two months in one patient, whereas information regarding the administration period was not available for the other patient.